Willows Veterinary Centre and Referral Service has introduced the cat and dog service to coincide with the launch of a pharmaceutical company’s new treatment option.
European Medicines Agency issues positive opinion for MSD Animal Health’s Bravecto, which, if approved, would be “first and only once-yearly injectable flea and tick medication” for dogs.
NoBACZ Healthcare, a University of Cambridge spin-off, says “revolutionary” product uses a patented natural polymer combined with copper and zinc ions that set rapidly on contact with skin.
Boehringer Ingelheim says its once-daily velagliflozin oral solution Senvelgo “ushers in a new era of care that enables diabetic cats and their owners to live normal lives despite this chronic condition”.
Manufacturer of Ketofen says resources designed around the “fab five” foot treatment team of farmers, vets, foot trimmers, mobility scorers and nutritional consultants.
Fluboral, containing flubendazole and combined with the company’s “unique” Solustab formulation, created to control gastrointestinal nematodes in both species.
UK-based firm secures patent for its DRC lighting system which, the company claims, offers enhanced patient monitoring and recovery, superior hygiene and improvements in operational efficiency.
Avishield IB H120 can now be used in all production lines of chickens including broilers, breeding chickens, future layers and adult laying hens, with no impact on egg production.
